Emerging use of nanoparticles in diagnosis and treatment of breast cancer (Q36556174)

14 August 2017

1 reference

title

Emerging use of nanoparticles in diagnosis and treatment of breast cancer (English)

1 reference

14 August 2017

0 references

1 reference

5

Shuming Nie

1 reference

14 August 2017

Maksym V Yezhelyev

1

1 reference

14 August 2017

Xiaohu Gao

2

1 reference

14 August 2017

Yun Xing

3

1 reference

14 August 2017

Ahmad Al-Hajj

4

1 reference

14 August 2017

Ruth M O'Regan

6

1 reference

14 August 2017

publication date

1 August 2006

1 reference

Lancet Oncology Commission

14 August 2017

published in

1 reference

14 August 2017

volume

7

1 reference

14 August 2017

issue

8

1 reference

14 August 2017

page(s)

657-667

1 reference

Nanotechnology in clinical laboratory diagnostics

14 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970793-8

7 January 2021

Cancer nanotechnology: opportunities and challenges

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970793-8

7 January 2021

Personalised medicine for cancer: from drug development into clinical practice

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970793-8

7 January 2021

Method for multiplex cellular detection of mRNAs using quantum dot fluorescent in situ hybridization

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970793-8

7 January 2021

Nanobiotechnology: the promise and reality of new approaches to molecular recognition

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970793-8

7 January 2021

In vivo cancer targeting and imaging with semiconductor quantum dots

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970793-8

7 January 2021

MR molecular imaging of the Her-2/neu receptor in breast cancer cells using targeted iron oxide nanoparticles

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970793-8

7 January 2021

Reduced cardiotoxicity and preserved antitumor efficacy of liposome-encapsulated doxorubicin and cyclophosphamide compared with conventional doxorubicin and cyclophosphamide in a randomized, multicenter trial of metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970793-8

7 January 2021

Reduced cardiotoxicity and comparable efficacy in a phase III trial of pegylated liposomal doxorubicin HCl (CAELYX/Doxil) versus conventional doxorubicin for first-line treatment of metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970793-8

7 January 2021

Phase III Trial of Nanoparticle Albumin-Bound Paclitaxel Compared With Polyethylated Castor Oil–Based Paclitaxel in Women With Breast Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970793-8

7 January 2021

Multicenter phase II trial of ABI-007, an albumin-bound paclitaxel, in women with metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970793-8

7 January 2021

Liposome-based drug delivery in breast cancer treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970793-8

7 January 2021

Liposomal encapsulated anti-cancer drugs

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970793-8

7 January 2021

Designing dendrimers for biological applications

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970793-8

7 January 2021

Dendrimers in biomedical applications--reflections on the field

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970793-8

7 January 2021

Chemistry of carbon nanotubes

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970793-8

7 January 2021

Applications of carbon nanotubes in drug delivery

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970793-8

7 January 2021

The dawning era of polymer therapeutics

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970793-8

7 January 2021

Immunofluorescent labeling of cancer marker Her2 and other cellular targets with semiconductor quantum dots

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970793-8

7 January 2021

Quantum dot ligands provide new insights into erbB/HER receptor-mediated signal transduction

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970793-8

7 January 2021

In vivo molecular and cellular imaging with quantum dots

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970793-8

7 January 2021

Quantum dot bioconjugates for imaging, labelling and sensing

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970793-8

7 January 2021

A toxicologic review of quantum dots: toxicity depends on physicochemical and environmental factors

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970793-8

7 January 2021

Spectroscopic Tags Using Dye-Embedded Nanoparticles and Surface-Enhanced Raman Scattering

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970793-8

7 January 2021

Rapid and ultra-sensitive determination of enzyme activities using surface-enhanced resonance Raman scattering

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970793-8

7 January 2021

Assessment of silver and gold substrates for the detection of amphetamine sulfate by surface enhanced Raman scattering (SERS).

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970793-8

7 January 2021

Non-invasive detection of apoptosis using magnetic resonance imaging and a targeted contrast agent

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970793-8

7 January 2021

Simultaneous measurement of multiple active kinase states using polychromatic flow cytometry

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970793-8

7 January 2021

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970793-8

7 January 2021

Efficacy and safety of trastuzumab as a single agent in first-line treatment of HER2-overexpressing metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970793-8

7 January 2021

Quantitative association between HER-2/neu and steroid hormone receptors in hormone receptor-positive primary breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970793-8

7 January 2021

Estrogen receptor (ER) and progesterone receptor (PgR), by ligand-binding assay compared with ER, PgR and pS2, by immuno-histochemistry in predicting response to tamoxifen in metastatic breast cancer: a Southwest Oncology Group Study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970793-8

7 January 2021

Potentials and pitfalls of fluorescent quantum dots for biological imaging

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970793-8

7 January 2021

Long-term multiple color imaging of live cells using quantum dot bioconjugates

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970793-8

7 January 2021

Quantum-dot-tagged microbeads for multiplexed optical coding of biomolecules

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970793-8

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970793-8

7 January 2021

Semiconductor nanocrystal probes for human metaphase chromosomes

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970793-8

7 January 2021

Semiconductor nanocrystal conjugates, FISH and pH.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970793-8

7 January 2021

An X-ray computed tomography imaging agent based on long-circulating bismuth sulphide nanoparticles.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970793-8

7 January 2021

Diagnostic precision of nanoparticle-enhanced MRI for lymph-node metastases: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970793-8

7 January 2021

Medical application of functionalized magnetic nanoparticles

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970793-8

7 January 2021

Superparamagnetic iron oxide: enhanced detection of focal splenic tumors with MR imaging

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970793-8

7 January 2021

Nanocrystal targeting in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970793-8

7 January 2021

Quantum dots spectrally distinguish multiple species within the tumor milieu in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970793-8

7 January 2021

Tracking metastatic tumor cell extravasation with quantum dot nanocrystals and fluorescence emission-scanning microscopy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970793-8

7 January 2021

Near-infrared fluorescent type II quantum dots for sentinel lymph node mapping

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970793-8

7 January 2021

Clinical aspects of sentinel node biopsy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970793-8

7 January 2021

Sentinel lymph node biopsy in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970793-8

7 January 2021

Allergic reactions to isosulfan blue in sentinel lymph node mapping.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970793-8

7 January 2021

Sentinel lymph node biopsy: sentinel node technique has drawbacks

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970793-8

7 January 2021

Nanoshell-mediated near-infrared thermal therapy of tumors under magnetic resonance guidance

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970793-8

7 January 2021

Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970793-8

7 January 2021

Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970793-8

7 January 2021

Cremophor EL: the drawbacks and advantages of vehicle selection for drug formulation

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970793-8

7 January 2021

Hypersensitivity reactions from taxol

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970793-8

7 January 2021

Comparative preclinical and clinical pharmacokinetics of a cremophor-free, nanoparticle albumin-bound paclitaxel (ABI-007) and paclitaxel formulated in Cremophor (Taxol).

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970793-8

7 January 2021

Poly(ethylene oxide)-modified poly(epsilon-caprolactone) nanoparticles for targeted delivery of tamoxifen in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970793-8

7 January 2021

Gene therapy for breast cancer. --Review of clinical gene therapy trials for breast cancer and MDR1 gene therapy trial in Cancer Institute Hospital

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970793-8

7 January 2021

Oncogenes and tumor suppressor genes in breast cancer: potential diagnostic and therapeutic applications

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970793-8

7 January 2021

Genospheres: self-assembling nucleic acid-lipid nanoparticles suitable for targeted gene delivery.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970793-8

7 January 2021

Cationic liposome-mediated E1A gene transfer to human breast and ovarian cancer cells and its biologic effects: a phase I clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970793-8

7 January 2021

Nanoparticle-mediated wild-type p53 gene delivery results in sustained antiproliferative activity in breast cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970793-8

7 January 2021

Pharmacological and small interference RNA-mediated inhibition of breast cancer-associated fatty acid synthase (oncogenic antigen-519) synergistically enhances Taxol (paclitaxel)-induced cytotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970793-8

7 January 2021

Small interfering RNA (siRNA) inhibits the expression of the Her2/neu gene, upregulates HLA class I and induces apoptosis of Her2/neu positive tumor cell lines.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970793-8

7 January 2021

Antisense oligonucleotides adsorbed to polyalkylcyanoacrylate nanoparticles specifically inhibit mutated Ha-ras-mediated cell proliferation and tumorigenicity in nude mice

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970793-8

7 January 2021

RNAi-mediated gene-targeting through systemic application of polyethylenimine (PEI)-complexed siRNA in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970793-8

7 January 2021

10.1016/S1470-2045(06)70793-8

Identifiers

DOI

1 reference

14 August 2017

1 reference